AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca scope 3 Cat 12 — End-of-life treatment of sold products (tCO2e)
Sustainability Data Annex — Scope 3 GHG Emissions
Latest, FY2025
19,531
Period ended Dec 31, 2025
Change on a year earlier
+24.3%
15,713 in FY2024
History
5 years
Since FY2019
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 3 Cat 12 — End-of-life treatment of sold products (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 19,531 | +24.3% | Sustainability Data Annex 2025 ↗ |
| FY2024 | Dec 31, 2024 | 15,713 | +7.8% | Sustainability Data Annex 2025 ↗ |
| FY2023 | Dec 31, 2023 | 14,579 | +7.4% | Sustainability Data Annex 2025 ↗ |
| FY2022 | Dec 31, 2022 | 13,572 | – | Sustainability Data Annex 2024 ↗ |
| FY2019 | Dec 31, 2019 | 16,122 | – | Sustainability Data Annex 2025 ↗ |
Cite this data
StockData. (2026). AstraZeneca Scope 3 Cat 12 — End-of-life treatment of sold products (tCO2e), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/esg_scope3_cat12
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.